Modulation of Amniotic Fluid Activin-A and Inhibin-A in Women With Preterm Premature Rupture of the Membranes and Infection-Induced Preterm Birth

American Journal of Reproductive Immunology

Volumn 67, Issue 2, 2012, Pages 122-131

  Rosenberg, Victor A ^a,b   Buhimschi, Irina A ^a   Dulay, Antonette T ^a   Abdel Razeq, Sonya S ^a   Oliver, Emily A ^a,c   Duzyj, Christina M ^a   Lipkind, Heather ^a   Pettker, Christian M ^a   Buhimschi, Catalin S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Activin; Endotoxin; Fetal membranes; Infection; Inflammation; Inhibin; Preterm labor

Indexed keywords

ACTIVIN A; BACTERIUM LIPOPOLYSACCHARIDE; INHIBIN A; INTERLEUKIN 8;

AMNION; AMNION FLUID ANALYSIS; AMNION FLUID LEVEL; AMNIONITIS; ARTICLE; CYTOKINE RELEASE; FEMALE; FETUS MEMBRANE; GESTATIONAL AGE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PLACENTA VILLUS; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN SECRETION; UPREGULATION;

ACTIVINS; AMNIOTIC FLUID; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; INHIBINS; INTERLEUKIN-6; INTERLEUKIN-8; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH;

EID: 84855347801     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2011.01074.x     Document Type: Article

References (40)

1. Xia Y, Schneyer AL: The biology of activin: recent advances in structure, regulation and function. J Endocrinol 2009; 202:1-12.
2. Mather JP, Roberts PE, Krummen LA: Follistatin modulates activin activity in a cell- and tissue-specific manner. Endocrinology 1993; 132:2732-2734.
3. Mathews LS, Vale WW: Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 1991; 65:973-982.
4. Phillips DJ, Woodruff TK: Inhibin: actions and signalling. Growth Factors 2004; 22:13-18.
5. Yokoyama Y, Nakamura T, Nakamura R, Irahara M, Aono T, Sugino H: Identification of activins and follistatin proteins in human follicular fluid and placenta. J Clin Endocrinol Metab 1995; 80:915-921.
6. Welt CK: The physiology and pathophysiology of inhibin, activin and follistatin in female reproduction. Curr Opin Obstet Gynecol 2002; 14:317-323.
7. Hedger MP, Winnall WR, Phillips DJ, de Kretser DM: The regulation and functions of activin and follistatin in inflammation and immunity. Vitam Horm 2011; 85:255-297.
8. Aleman-Muench GR, Soldevila G: When versatility matters: activins/inhibins as key regulators of immunity. Immunol Cell Biol 2011; PMID: 21537340.
9. Chen Y, Wu H, Winnall WR, Loveland KL, Makanji Y, Phillips DJ, Smith JA, Hedger MP: Tumour necrosis factor-α stimulates human neutrophils to release preformed activin A. Immunol Cell Biol 2011; PMID: 21445090.
10. Sugatani T, Alvarez UM, Hruska KA: Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors. J Cell Biochem 2003; 90:59-67.
11. Ohguchi M, Yamato K, Ishihara Y, Koide M, Ueda N, Okahashi N, Noguchi T, Kizaki M, Ikeda Y, Sugino H, Nisihara T: Activin A regulates the production of mature interleukin-1beta and interleukin-1 receptor antagonist in human monocytic cells. J Interferon Cytokine Res 1998; 18:491-498.
12. Keelan JA, Zhou RL, Mitchell MD: Activin A exerts both pro- and anti-inflammatory effects on human term gestational tissues. Placenta 2000; 21:38-43.
13. Jones KL, Mansell A, Patella S, Scott BJ, Hedger MP, de Kretser DM, Phillips DJ: Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci USA 2007; 104:16239-16244.
14. Jones RL, Findlay JK, Farnworth PG, Robertson DM, Wallace E, Salamonsen LA: Activin A and inhibin A differentially regulate human uterine matrix metalloproteinases: potential interactions during decidualization and trophoblast invasion. Endocrinology 2006; 147:724-732.
15. Florio P, Luisi S, Ciarmela P, Severi FM, Bocchi C, Petraglia F: Inhibins and activins in pregnancy. Mol Cell Endocrinol 2004; 225:93-100.
16. Petraglia F, Gallinelli A, Grande A, Florio P, Ferrari S, Genazzani AR, Ling N, DePaolo LV: Local production and action of follistatin in human placenta. J Clin Endocrinol Metab 1994; 78:205-210.
17. Petraglia F, Di Blasio AM, Florio P, Gallo R, Genazzani AR, Woodruff TK, Vale W: High levels of fetal membrane activin beta A and activin receptor IIB mRNAs and augmented concentration of amniotic fluid activin A in women in term or preterm labor. J Endocrinol 1997; 154:95-101.
18. Riley SC, Wathen NC, Chard T, Groome NP, Wallace EM: Inhibin in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Hum Reprod 1996; 11:2772-2776.
19. Buhimschi IA, Christner R, Buhimschi CS: Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG 2005; 112:173-181.
20. Buhimschi CS, Bhandari V, Hamar BD, Bahtiyar MO, Zhao G, Sfakianaki AK, Pettker CM, Magloire L, Funai E, Norwitz ER, Paidas M, Copel JA, Weiner CP, Lockwood CJ, Buhimschi IA: Proteomic profiling of the AF to detect inflammation, infection, and neonatal sepsis. PLoS Med 2007; 4:e18.
21. Buhimschi CS, Bhandari V, Dulay AT, Thung S, Razeq SS, Rosenberg V, Han CS, Ali UA, Zambrano E, Zhao G, Funai EF, Buhimschi IA: Amniotic fluid angiopoietin-1, angiopoietin-2, and soluble receptor tunica interna endothelial cell kinase-2 levels and regulation in normal pregnancy and intraamniotic inflammation-induced preterm birth. J Clin Endocrinol Metab 2010; 95:3428-3436.
22. El Mansouri L, Bahiri R, Abourazzak FE, Abouqal R, Hajjaj-Hassouni N: Two distinct patterns of ankylosing spondylitis in Moroccan patients. Rheumatol Int 2009; 29:1423-1429.
23. Petraglia F, Calzà L, Garuti GC, Abrate M, Giardino L, Genazzani AR, Vale W, Meunier H: Presence and synthesis of inhibin subunits in human decidua. J Clin Endocrinol Metab 1990; 71:487-492.
24. Wallace EM, Riley SC, Crossley JA, Ritoe SC, Horne A, Shade M, Ellis PM, Aitken DA, Groome NP: Dimeric inhibins in amniotic fluid, maternal serum, and fetal serum in human pregnancy. J Clin Endocrinol Metab 1997; 82:218-222.
25. Wallace EM, D'Antona D, Shearing C, Evans LW, Thirunavukarasu P, Ashby JP, Shade M, Groome NP: Amniotic fluid levels of dimeric inhibins, pro-alpha C inhibin, activin A and follistatin in Down's syndrome. Clin Endocrinol (Oxf) 1999; 50:669-673.
26. Muttukrishna S, Chamberlain P, Evans LW, Asselin J, Groome NP, Ledger WL: Amniotic fluid concentrations of dimeric inhibins, activin A and follistatin in pregnancy. Eur J Endocrinol 1999; 140:420-424.
27. Riley SC, Balfour C, Wathen NC, Chard T, Evans LW, Groome NP, Wallace EM: Follistatin and activin A in extra-embryonic coelomic and amniotic fluids and maternal serum in early pregnancy. Hum Reprod 1998; 13:2624-2628.
28. Luisi S, Battaglia C, Florio P, D'Ambrogio G, Taponeco F, Santuz M, Genazzani AR, Petraglia F: Activin A and inhibin B in extra-embryonic coelomic and amniotic fluids, and maternal serum in early pregnancy. Placenta 1998; 19:435-438.
29. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992; 359:693-699.
30. Michel U, Ebert S, Phillips D, Nau R: Serum concentrations of activin and follistatin are elevated and run in parallel in patients with septicemia. Eur J Endocrinol 2003; 148:559-564.
31. Michel U, Gerber J, E O'Connor A, Bunkowski S, Brück W, Nau R, Phillips DJ: Increased activin levels in cerebrospinal fluid of rabbits with bacterial meningitis are associated with activation of microglia. J Neurochem 2003; 86:238-245.
32. Keelan JA, Zhou RL, Evans LW, Groome NP, Mitchell MD: Regulation of activin A, inhibin A, and follistatin production in human amnion and choriodecidual explants by inflammatory mediators. J Soc Gynecol Investig 2000; 7:291-296.
33. Dulay AT, Buhimschi CS, Zhao G, Oliver EA, Mbele A, Jing S, Buhimschi IA: Soluble TLR2 is present in human amniotic fluid and modulates the intraamniotic inflammatory response to infection. J Immunol 2009; 182:7244-7253.
34. Ma Y, Krikun G, Abrahams VM, Mor G, Guller S: Cell type-specific expression and function of toll-like receptors 2 and 4 in human placenta: implications in fetal infection. Placenta 2007; 28:1024-1031.
35. Moore RM, Mansour JM, Redline RW, Mercer BM, Moore JJ: The physiology of fetal membrane rupture: insight gained from the determination of physical properties. Placenta 2006; 27:1037-1051.
36. Ota A, Yonemoto H, Someya A, Itoh S, Kinoshita K, Nagaoka I: Changes in matrix metalloproteinase 2 activities in amniochorions during premature rupture of membranes. J Soc Gynecol Investig 2006; 13:592-597.
37. Vadillo-Ortega F, González-Avila G, Furth EE, Lei H, Muschel RJ, Stetler-Stevenson WG, Strauss JF 3rd: 92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am J Pathol 1995; 146:148-156.
38. Schneider-Kolsky ME, Manuelpillai U, Waldron K, Dole A, Wallace EM: The distribution of activin and activin receptors in gestational tissues across human pregnancy and during labour. Placenta 2002; 23:294-302.
39. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF 3rd, Petraglia F: Inflammation and pregnancy. Reprod Sci 2009; 16:206-215.
40. Lee SY, Buhimschi IA, Dulay AT, Ali UA, Zhao G, Abdel-Razeq SS, Bahtiyar MO, Thung SF, Funai EF, Buhimschi CS: IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes. J Immunol 2011; 186:3226-3236.